Addressing Clinical Limitations of Glutaminase Inhibitors: Novel Strategies for Osimertinib‐Resistant Lung Cancer by Exploiting Glutamine Metabolic Dependency.
Saved in:
| Title: | Addressing Clinical Limitations of Glutaminase Inhibitors: Novel Strategies for Osimertinib‐Resistant Lung Cancer by Exploiting Glutamine Metabolic Dependency. |
|---|---|
| Authors: | Huang, Jiali1,2 (AUTHOR), Zhang, Xiankang1 (AUTHOR), Zhang, Hui1 (AUTHOR), Li, Yu1 (AUTHOR), Huang, Huidan3 (AUTHOR), Li, Zhiyu1 (AUTHOR) zhiyuli@cpu.edu.cn, Qiu, Zhixia1 (AUTHOR), Wu, Hongxi1 (AUTHOR), Huang, Dechun2 (AUTHOR) cpuhdc@cpu.edu.cn, Xu, Xi1 (AUTHOR) xuxi@cpu.edu.cn, Bian, Jinlei1 (AUTHOR) bianjl@cpu.edu.cn |
| Source: | Advanced Science. Dec2024, p1. 17p. 9 Illustrations. |
| Database: | Academic Search Ultimate |
| ISSN: | 21983844 |
|---|---|
| DOI: | 10.1002/advs.202411479 |
